ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED

Balance Sheet Alibaba Health Information Technology Limited

Stocks

241 BMG0171K1018

Drug Retailers

Market Closed - Hong Kong S.E. Other stock markets 01:38:21 12/06/2026 pm IST			5-day change	1st Jan Change
3.510 ^HKD	+2.93%		-2.23%	-30.50%

26/05	Alibaba Health is Winning Battles but Losing the War
20/05	Jefferies Adjusts Alibaba Health Information Technology's Price Target to HK$5.30 from HK$6, Keeps at Buy	MT

8ded57c4.x46bgadePhPH4b8eaSk2zxXJUeZnQJJGPHKyE12thu4.qb_O7dY6VlTqmf5SCEBn_HaKJ6QILaoiDjbzW2_397Ty7Muyz2dUXamV8g

Published financial data: ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	1.55TCr	2.06TCr	2.68TCr	2.7TCr	3.06TCr
Total Revenues	1.55TCr	2.06TCr	2.68TCr	2.7TCr	3.06TCr
Cost of Goods Sold, Total	1.19TCr	1.65TCr	2.11TCr	2.11TCr	2.32TCr
Gross Profit	360.29Cr	410.8Cr	570.13Cr	589.53Cr	743.21Cr
Selling General & Admin Expenses, Total	313.51Cr	447.1Cr	505.53Cr	454.98Cr	523.35Cr
R&D Expenses	42Cr	73Cr	68Cr	71Cr	72Cr
Other Operating Expenses	79.07L	39.51L	1.97Cr	53.33L	2.49Cr
Other Operating Expenses, Total	356.66Cr	520.38Cr	575.28Cr	526.05Cr	597.85Cr
Operating Income	3.63Cr	-109.58Cr	-5.15Cr	63Cr	145.36Cr
Interest Expense, Total	-24.49L	-38.15L	-58.33L	-59.69L	-26.09L
Interest And Investment Income	17Cr	21Cr	33Cr	51Cr	49Cr
Net Interest Expenses	16Cr	21Cr	33Cr	50Cr	49Cr
Income (Loss) On Equity Invest.	-3.84Cr	-4.56Cr	1.14Cr	-59.26L	-6.47Cr
Currency Exchange Gains (Loss)	3.24Cr	3.97Cr	7.21Cr	70.86L	-3.71Cr
Other Non Operating Income (Expenses)	6.91Cr	10Cr	9.92Cr	9.22Cr	12Cr
EBT, Excl. Unusual Items	26Cr	-79Cr	46Cr	123.08Cr	195.88Cr
Merger & Related Restructuring Charges	-	-26.31L	-	-	-
Gain (Loss) On Sale Of Investments	6.69Cr	54Cr	11Cr	-28Cr	-40Cr
Gain (Loss) On Sale Of Assets	7.06Cr	1L	-12.43L	5L	6L
Other Unusual Items	-	-27.82L	-1.95Cr	-84.57L	-
EBT, Incl. Unusual Items	40Cr	-25Cr	55Cr	94Cr	156Cr
Income Tax Expense	5.85Cr	1.34Cr	1.67Cr	5.63Cr	13Cr
Earnings From Continuing Operations	34Cr	-27Cr	53Cr	88Cr	143.2Cr
Net Income to Company	34Cr	-27Cr	53Cr	88Cr	143.2Cr
Minority Interest	59.08L	4L	-9L	3L	4L
Net Income - (IS)	35Cr	-27Cr	53Cr	88Cr	143.24Cr
Net Income to Common Incl Extra Items	35Cr	-27Cr	53Cr	88Cr	143.24Cr
Net Income to Common Excl. Extra Items	35Cr	-27Cr	53Cr	88Cr	143.24Cr
Per Share Items
Net EPS - Basic	0.03	-0.02	0.04	0.06	0.09
Basic EPS - Continuing Operations	0.03	-0.02	0.04	0.06	0.09
Basic Weighted Average Shares Outstanding	1.32TCr	1.35TCr	1.35TCr	1.4TCr	1.61TCr
Net EPS - Diluted	0.03	-0.02	0.04	0.06	0.09
Diluted EPS - Continuing Operations	0.03	-0.02	0.04	0.06	0.09
Diluted Weighted Average Shares Outstanding	1.33TCr	1.35TCr	1.35TCr	1.41TCr	1.61TCr
Normalized Basic EPS	0.01	-0.04	0.02	0.05	0.08
Normalized Diluted EPS	0.01	-0.04	0.02	0.05	0.08
American Depositary Receipts Ratio (ADR)	20	20	20	20	20
Supplemental Items
EBITDA	5.09Cr	-107.39Cr	-2.45Cr	66Cr	148.57Cr
EBITA	3.83Cr	-108.39Cr	-3.4Cr	65Cr	147.05Cr
EBIT	3.63Cr	-109.58Cr	-5.15Cr	63Cr	145.36Cr
EBITDAR	5.12Cr	-107.3Cr	-2.34Cr	66Cr	148.79Cr
Effective Tax Rate - (Ratio)	14.59	-5.32	3.04	5.99	8.2
Current Domestic Taxes	3.93Cr	3.45Cr	3.12Cr	8.46Cr	14Cr
Total Current Taxes	3.93Cr	3.45Cr	3.12Cr	8.46Cr	14Cr
Deferred Domestic Taxes	1.92Cr	-2.11Cr	-1.45Cr	-	-
Total Deferred Taxes	1.92Cr	-2.11Cr	-1.45Cr	-2.84Cr	-1.06Cr
Normalized Net Income	17Cr	-49Cr	28Cr	77Cr	122.47Cr
Interest on Long-Term Debt	24.49L	38.15L	58.33L	59.69L	26.09L
Supplemental Operating Expense Items
Selling and Marketing Expenses	122.2Cr	198.13Cr	176.87Cr	177.66Cr	225.84Cr
General and Administrative Expenses	29Cr	39Cr	38Cr	36Cr	41Cr
Research And Development Expense From Footnotes	42Cr	73Cr	68Cr	71Cr	72Cr
Net Rental Expense, Total	3L	9L	11.26L	16.52L	21.31L
Imputed Operating Lease Interest Expense	1L	3L	5L	10L	8L
Imputed Operating Lease Depreciation	2L	6L	6L	7L	13.75L
Stock-Based Comp., COGS (Total)	1.65Cr	1.61Cr	1.54Cr	1.28Cr	98.04L
Stock-Based Comp., R&D Exp. (Total)	14Cr	14Cr	9.87Cr	7.98Cr	9.03Cr
Stock-Based Comp., S&M Exp. (Total)	12Cr	12Cr	8.93Cr	6.57Cr	1.88Cr
Stock-Based Comp., G&A Exp. (Total)	9.03Cr	9.85Cr	6.94Cr	7.6Cr	7.67Cr
Stock-Based Comp., SG&A Exp. (Total)	3.01Cr	3.37Cr	3.61Cr	3.17Cr	2.9Cr
Total Stock-Based Compensation	40Cr	41Cr	31Cr	27Cr	22Cr

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	1.16TCr	1.05TCr	1.09TCr	955.31Cr	221.83Cr
Short Term Investments	-	-	-	-	561.79Cr
Trading Asset Securities, Total	-	-	-	-	26Cr
Total Cash And Short Term Investments	1.16TCr	1.05TCr	1.09TCr	955.31Cr	809.98Cr
Accounts Receivable, Total	31Cr	52Cr	58Cr	79Cr	105.25Cr
Other Receivables	46Cr	56Cr	70Cr	112.58Cr	102.09Cr
Total Receivables	77Cr	107.39Cr	127.93Cr	191.1Cr	207.34Cr
Inventory	146.86Cr	155.02Cr	210.23Cr	139.97Cr	141.52Cr
Prepaid Expenses	31Cr	33Cr	46Cr	37Cr	38Cr
Restricted Cash	1.1Cr	6.31Cr	15Cr	28Cr	30Cr
Other Current Assets, Total	-	-	-	-	-
Total Current Assets	1.42TCr	1.36TCr	1.49TCr	1.35TCr	1.23TCr
Gross Property Plant And Equipment	13Cr	25Cr	15Cr	17Cr	14Cr
Accumulated Depreciation	-8.13Cr	-8Cr	-8.23Cr	-7.12Cr	-7.45Cr
Net Property Plant And Equipment	5.23Cr	17Cr	6.85Cr	10Cr	6.97Cr
Long-term Investments	341.36Cr	429.66Cr	459.15Cr	490.01Cr	760.21Cr
Goodwill	5.46Cr	81Cr	81Cr	81Cr	81Cr
Other Intangibles, Total	29.35L	33Cr	31Cr	29Cr	28Cr
Loans Receivable Long-Term	-	-	-	-	-
Deferred Tax Assets Long-Term	-	1.74Cr	3.38Cr	5.49Cr	5.08Cr
Other Long-Term Assets, Total	1.61Cr	2.03Cr	2Cr	3.16Cr	9.35Cr
Total Assets	1.77TCr	1.92TCr	2.07TCr	1.97TCr	2.12TCr
Liabilities
Accounts Payable, Total	255.16Cr	352.86Cr	371.4Cr	335.06Cr	285.24Cr
Accrued Expenses, Total	11Cr	17Cr	18Cr	9.27Cr	22Cr
Short-term Borrowings	-	-	-	-	-
Current Portion of Leases	2.03Cr	5.07Cr	3.74Cr	3.42Cr	1.06Cr
Current Income Taxes Payable	5.03Cr	4.08Cr	6.34Cr	8.89Cr	14Cr
Unearned Revenue Current, Total	19Cr	26Cr	50Cr	55Cr	70Cr
Other Current Liabilities	48Cr	77Cr	95Cr	90Cr	83Cr
Total Current Liabilities	340.09Cr	482.21Cr	543.74Cr	502.55Cr	474.22Cr
Long-Term Debt	-	-	-	-	-
Long-Term Leases	1.74Cr	8.48Cr	4.04Cr	4.8Cr	2.49Cr
Deferred Tax Liability Non Current	3.93Cr	12Cr	12Cr	11Cr	9.81Cr
Other Non Current Liabilities	-	11Cr	-	-	-
Total Liabilities	345.76Cr	512.97Cr	560.02Cr	518.77Cr	486.53Cr
Common Stock, Total	12Cr	12Cr	12Cr	14Cr	14Cr
Additional Paid In Capital	4.33TCr	4.35TCr	4.37TCr	5.14TCr	5.15TCr
Retained Earnings	-99Cr	-130.9Cr	-84Cr	-1.2Cr	132.45Cr
Treasury Stock	-2.23Cr	-2.35Cr	-7.05Cr	-10Cr	-5.26Cr
Comprehensive Income and Other	-2.81TCr	-2.82TCr	-2.78TCr	-3.69TCr	-3.66TCr
Total Common Equity	1.43TCr	1.41TCr	1.52TCr	1.45TCr	1.63TCr
Minority Interest	-2.03Cr	-2.62Cr	-2.64Cr	-2.66Cr	10L
Total Equity	1.43TCr	1.41TCr	1.51TCr	1.45TCr	1.63TCr
Total Liabilities And Equity	1.77TCr	1.92TCr	2.07TCr	1.97TCr	2.12TCr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	1.35TCr	1.35TCr	1.35TCr	1.46TCr	1.61TCr
ECS Total Common Shares Outstanding	1.35TCr	1.35TCr	1.35TCr	1.46TCr	1.61TCr
Book Value / Share	1.06	1.05	1.12	1	1.01
Tangible Book Value	1.42TCr	1.3TCr	1.41TCr	1.34TCr	1.52TCr
Tangible Book Value Per Share	1.06	0.96	1.04	0.92	0.95
Total Debt	3.77Cr	14Cr	7.78Cr	8.22Cr	3.55Cr
Net Debt	-1.16TCr	-1.04TCr	-1.08TCr	-947.09Cr	-806.43Cr
Debt Equivalent Oper. Leases	25.36L	70.24L	90.08L	1.32Cr	1.7Cr
Minority Interest, Total (Incl. Fin. Div)	-2.03Cr	-2.62Cr	-2.64Cr	-2.66Cr	10L
Equity Method Investments, Total	227.25Cr	250.15Cr	258.61Cr	253.64Cr	173Cr
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Finished Goods, Total	-	155.02Cr	210.23Cr	139.97Cr	141.52Cr
Machinery, Total	7.86Cr	7.48Cr	7.14Cr	8.19Cr	8.64Cr
Full Time Employees	1.03T	1.85T	1.56T	1.44T	1.36T
Accumulated Allowance for Doubtful Accounts (Supple)	2.66Cr	2.67Cr	2.85Cr	3.37Cr	3.63Cr

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	35Cr	-27Cr	53Cr	88Cr	143.24Cr
Depreciation & Amortization - CF	3.76Cr	4.87Cr	4.62Cr	3.67Cr	4.08Cr
Amortization of Goodwill and Intangible Assets - (CF)	20.13L	1.19Cr	1.75Cr	1.7Cr	1.68Cr
Depreciation & Amortization, Total	3.96Cr	6.06Cr	6.37Cr	5.37Cr	5.76Cr
(Gain) Loss From Sale Of Asset	-7.05Cr	-1L	12.43L	-5L	-6L
(Gain) Loss on Sale of Investments - (CF)	-6.57Cr	-54Cr	-11Cr	28Cr	40Cr
Provision for Credit Losses	-	-	-	-25L	-
(Income) Loss On Equity Investments - (CF)	3.84Cr	4.56Cr	-1.14Cr	59.26L	6.47Cr
Stock-Based Compensation (CF)	40Cr	41Cr	31Cr	27Cr	22Cr
Provision and Write-off of Bad Debts	-3L	1L	18.24L	51.43L	62.07L
Other Operating Activities, Total	-1.42Cr	6.36Cr	3.84Cr	-7.74Cr	-22Cr
Change In Accounts Receivable	74.39L	-20Cr	-6.46Cr	-21Cr	-27Cr
Change In Inventories	-28Cr	-13Cr	-71Cr	61Cr	-11Cr
Change In Accounts Payable	72Cr	96Cr	19Cr	-36Cr	-50Cr
Change in Unearned Revenues	1.93Cr	7.01Cr	23Cr	5.96Cr	14Cr
Change in Other Net Operating Assets	-12Cr	-4.44Cr	-21Cr	-44Cr	17Cr
Cash from Operations	100.94Cr	42Cr	26Cr	107.98Cr	139.5Cr
Capital Expenditure	-1.71Cr	-1.49Cr	-56.12L	-2.28Cr	-1.89Cr
Sale of Property, Plant, and Equipment	8L	18.56L	4L	7L	59.66L
Cash Acquisitions	-	-82Cr	-7.73Cr	-13Cr	-
Divestitures	-1.06Cr	-	-	-	-
Sale (Purchase) of Intangible assets	-5L	-2L	-3L	-6T	-10T
Investment in Marketable and Equity Securities, Total	-472.46Cr	279.94Cr	-51Cr	-485.71Cr	-294.3Cr
Net (Increase) Decrease in Loans Originated / Sold - Investing	2.5Cr	1.39Cr	-	1.34Cr	1.06Cr
Other Investing Activities, Total	-23Cr	-11Cr	6.29Cr	12Cr	35Cr
Cash from Investing	-496.15Cr	187.23Cr	-53Cr	-488.09Cr	-259.65Cr
Short Term Debt Issued, Total	-	-	-	-	-
Long-Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	-	-	-	-	-
Short Term Debt Repaid, Total	-	-	-	-	-
Long-Term Debt Repaid, Total	-3.16Cr	-4.7Cr	-4.26Cr	-3.99Cr	-3.81Cr
Total Debt Repaid	-3.16Cr	-4.7Cr	-4.26Cr	-3.99Cr	-3.81Cr
Issuance of Common Stock	899.37Cr	96.93L	1.29Cr	9L	45.87L
Repurchase of Common Stock	-3.96Cr	-1.65Cr	-8.16Cr	-10Cr	-3.99Cr
Other Financing Activities, Total	-1L	-47.9L	-	-183.88Cr	9L
Cash from Financing	892.24Cr	-5.86Cr	-11Cr	-198.24Cr	-7.25Cr
Foreign Exchange Rate Adjustments	-31Cr	-15Cr	28Cr	3.68Cr	20.93L
Net Change in Cash	465.73Cr	208.92Cr	-10Cr	-574.67Cr	-127.19Cr
Supplemental Items
Cash Interest Paid	24.49L	38.15L	58.33L	59.69L	26.09L
Cash Income Tax Paid (Refund)	2.79Cr	4.53Cr	4.31Cr	4.06Cr	11Cr
Levered Free Cash Flow	70Cr	70Cr	-1.96Cr	32Cr	69Cr
Unlevered Free Cash Flow	70Cr	70Cr	-1.59Cr	32Cr	69Cr
Change In Net Working Capital	-26Cr	-94Cr	35Cr	37Cr	48Cr
Net Debt Issued / Repaid	-3.16Cr	-4.7Cr	-4.26Cr	-3.99Cr	-3.81Cr

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	0.18	-3.71	-0.16	1.96	4.44
Return on Total Capital	0.23	-4.8	-0.22	2.66	5.87
Return On Equity %	3.52	-1.88	3.66	5.95	9.29
Return on Common Equity	3.56	-1.87	3.64	5.95	9.28
Margin Analysis
Gross Profit Margin %	23.22	19.96	21.3	21.81	24.29
SG&A Margin	20.2	21.73	18.89	16.83	17.1
EBITDA Margin %	0.33	-5.22	-0.09	2.44	4.86
EBITA Margin %	0.25	-5.27	-0.13	2.41	4.81
EBIT Margin %	0.23	-5.33	-0.19	2.35	4.75
Income From Continuing Operations Margin %	2.21	-1.29	2	3.27	4.68
Net Income Margin %	2.25	-1.29	1.99	3.27	4.68
Net Avail. For Common Margin %	2.25	-1.29	1.99	3.27	4.68
Normalized Net Income Margin	1.1	-2.4	1.06	2.85	4
Levered Free Cash Flow Margin	4.48	3.41	-0.07	1.18	2.27
Unlevered Free Cash Flow Margin	4.49	3.43	-0.06	1.19	2.27
Asset Turnover
Asset Turnover	1.21	1.11	1.34	1.34	1.5
Fixed Assets Turnover	229.53	189.31	229.08	313.87	352.95
Receivables Turnover (Average Receivables)	48.64	49.61	48.89	39.63	33.3
Inventory Turnover (Average Inventory)	8.87	10.91	11.53	12.07	16.46
Short Term Liquidity
Current Ratio	4.18	2.81	2.74	2.69	2.59
Quick Ratio	3.65	2.41	2.24	2.28	2.15
Operating Cash Flow to Current Liabilities	0.3	0.09	0.05	0.21	0.29
Days Sales Outstanding (Average Receivables)	7.5	7.36	7.47	9.24	10.96
Days Outstanding Inventory (Average Inventory)	41.14	33.45	31.65	30.33	22.18
Average Days Payable Outstanding	66.25	67.04	61.15	63.28	48.83
Cash Conversion Cycle (Average Days)	-17.61	-26.23	-22.04	-23.72	-15.7
Long Term Solvency
Total Debt/Equity	0.26	0.96	0.51	0.57	0.22
Total Debt / Total Capital	0.26	0.95	0.51	0.56	0.22
LT Debt/Equity	0.12	0.6	0.27	0.33	0.15
Long-Term Debt / Total Capital	0.12	0.6	0.26	0.33	0.15
Total Liabilities / Total Assets	19.49	26.71	26.99	26.33	22.97
EBIT / Interest Expense	14.8	-287.24	-8.83	106.36	557.15
EBITDA / Interest Expense	30.98	-271.36	2.09	115.35	579.23
(EBITDA - Capex) / Interest Expense	24.01	-275.27	1.13	111.54	571.99
Total Debt / EBITDA	0.5	-0.13	6.37	0.12	0.02
Net Debt / EBITDA	-152.86	10.06	-887.38	-13.76	-5.34
Total Debt / (EBITDA - Capex)	0.64	-0.13	11.78	0.12	0.02
Net Debt / (EBITDA - Capex)	-197.26	9.92	-1.64T	-14.23	-5.4
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	61.71	32.6	30.06	0.98	13.22
Gross Profit, 1 Yr. Growth %	61.85	13.57	38.79	3.4	26.07
EBITDA, 1 Yr. Growth %	-196.02	-2.16T	-97.73	-2.79T	125.54
EBITA, 1 Yr. Growth %	-158.03	-2.85T	-96.87	-2.02T	125.6
EBIT, 1 Yr. Growth %	-153.77	-3.02T	-95.31	-1.33T	128.97
Earnings From Cont. Operations, 1 Yr. Growth %	-2.28T	-177.61	-300.9	64.61	62.15
Net Income, 1 Yr. Growth %	-5.39T	-176.18	-300.86	64.93	62.14
Normalized Net Income, 1 Yr. Growth %	-1.63T	-387.43	-157.55	170.33	59.14
Diluted EPS Before Extra, 1 Yr. Growth %	-4.47T	-175.19	-300	58.33	41.63
Accounts Receivable, 1 Yr. Growth %	-3.37	64.53	12.17	35.65	34.06
Inventory, 1 Yr. Growth %	20.65	5.55	35.62	-33.42	1.11
Net Property, Plant and Equip., 1 Yr. Growth %	-36.95	215.76	-58.48	51.23	-32.75
Total Assets, 1 Yr. Growth %	125.4	8.25	8.05	-5.02	7.48
Tangible Book Value, 1 Yr. Growth %	173.4	-9.01	8.43	-4.36	13.28
Common Equity, 1 Yr. Growth %	171.43	-1.42	7.63	-4.15	12.16
Cash From Operations, 1 Yr. Growth %	72.96	-57.96	-39.75	322.32	29.19
Capital Expenditures, 1 Yr. Growth %	125.68	-12.57	-62.41	305.81	-17.04
Levered Free Cash Flow, 1 Yr. Growth %	23.13	0.92	-102.79	-1.73T	117.48
Unlevered Free Cash Flow, 1 Yr. Growth %	20.48	1.04	-102.27	-2.12T	115.47
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	74.51	46.43	31.32	14.6	6.93
Gross Profit, 2 Yr. CAGR %	64.58	35.85	25.54	19.8	14.17
EBITDA, 2 Yr. CAGR %	-26.47	350.02	-31.48	-21.78	679.1
EBITA, 2 Yr. CAGR %	-37.57	305.42	-7.22	-22.55	557.72
EBIT, 2 Yr. CAGR %	-39.23	303.15	17.24	-23.98	431.26
Earnings From Cont. Operations, 2 Yr. CAGR %	93.24	311.62	24.86	82.23	63.37
Net Income, 2 Yr. CAGR %	106.25	534.99	23.7	82.4	63.53
Normalized Net Income, 2 Yr. CAGR %	90.58	563.59	28.84	24.73	107.41
Diluted EPS Before Extra, 2 Yr. CAGR %	88.01	472.99	22.63	78.41	49.75
Accounts Receivable, 2 Yr. CAGR %	-7.36	26.09	35.85	23.35	34.85
Inventory, 2 Yr. CAGR %	57	12.85	19.65	-4.98	-17.95
Net Property, Plant and Equip., 2 Yr. CAGR %	142.58	41.1	14.5	-20.76	0.85
Total Assets, 2 Yr. CAGR %	72.21	56.2	8.15	1.3	1.03
Tangible Book Value, 2 Yr. CAGR %	126.87	57.73	-0.67	1.83	4.09
Common Equity, 2 Yr. CAGR %	126.23	63.57	3	1.57	3.68
Cash From Operations, 2 Yr. CAGR %	59.58	-14.73	-49.67	59.52	133.58
Capital Expenditures, 2 Yr. CAGR %	67.29	40.46	-42.67	23.51	83.48
Levered Free Cash Flow, 2 Yr. CAGR %	28.94	11.53	-83.23	-32.56	495.09
Unlevered Free Cash Flow, 2 Yr. CAGR %	26.47	10.39	-84.89	-32.28	560.45
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	85.21	59.24	40.76	20.31	14.14
Gross Profit, 3 Yr. CAGR %	76.93	45.63	36.82	17.68	21.85
EBITDA, 3 Yr. CAGR %	-27.86	125.08	-22.72	132.91	11.34
EBITA, 3 Yr. CAGR %	-35.13	122.67	-19.82	154.62	10.61
EBIT, 3 Yr. CAGR %	-36.29	123.49	-8.59	156.84	9.79
Earnings From Cont. Operations, 3 Yr. CAGR %	46.48	42.57	224.08	37.1	75.28
Net Income, 3 Yr. CAGR %	48.26	47.98	332.66	36.34	75.38
Normalized Net Income, 3 Yr. CAGR %	47.2	118.88	194.07	64.94	35.28
Diluted EPS Before Extra, 3 Yr. CAGR %	31.04	38.52	303.44	33.76	65.19
Accounts Receivable, 3 Yr. CAGR %	50.84	12.19	21.27	35.78	26.82
Inventory, 3 Yr. CAGR %	49.19	37.54	19.98	-1.59	-2.99
Net Property, Plant and Equip., 3 Yr. CAGR %	102.75	164.86	-6.15	25.63	-24.98
Total Assets, 3 Yr. CAGR %	78.65	47.51	38.14	3.57	3.32
Tangible Book Value, 3 Yr. CAGR %	77.18	67.31	39.2	-1.92	5.51
Common Equity, 3 Yr. CAGR %	76.97	71.51	42.27	0.56	4.98
Cash From Operations, 3 Yr. CAGR %	143.09	2.3	-24.05	2.27	48.69
Capital Expenditures, 3 Yr. CAGR %	43.9	34.75	-9.48	10.07	8.16
Levered Free Cash Flow, 3 Yr. CAGR %	67.19	18.87	-67.4	-22.92	-0.37
Unlevered Free Cash Flow, 3 Yr. CAGR %	69.75	17.39	-69.8	-22.68	-0.4
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	207.34	112.48	61.41	39.61	26.1
Gross Profit, 5 Yr. CAGR %	148.54	85.46	54.37	34.69	27.27
EBITDA, 5 Yr. CAGR %	-24.87	40.27	-29	47.55	94.75
EBITA, 5 Yr. CAGR %	-29.27	39.88	-24.67	46.03	86.06
EBIT, 5 Yr. CAGR %	-30.03	40.19	-18.15	45.26	84.81
Earnings From Cont. Operations, 5 Yr. CAGR %	11.49	4.97	37.42	57.28	146.62
Net Income, 5 Yr. CAGR %	12.71	5.04	37.9	60.89	193.42
Normalized Net Income, 5 Yr. CAGR %	8.4	30.35	39.68	74.91	155.74
Diluted EPS Before Extra, 5 Yr. CAGR %	2.25	-4.95	27.61	53.27	171.68
Accounts Receivable, 5 Yr. CAGR %	394.56	68.05	44.66	16.53	26.53
Inventory, 5 Yr. CAGR %	-	59.22	36.59	18.63	3.06
Net Property, Plant and Equip., 5 Yr. CAGR %	51.53	100.74	61.32	63.45	-3.41
Total Assets, 5 Yr. CAGR %	67.43	62.79	46.16	26.93	21.89
Tangible Book Value, 5 Yr. CAGR %	63.44	62.08	40.56	37.17	23.92
Common Equity, 5 Yr. CAGR %	63.57	64.29	42.52	39.08	25.36
Cash From Operations, 5 Yr. CAGR %	53.83	13.4	29.48	22.19	19.04
Capital Expenditures, 5 Yr. CAGR %	14.35	47.48	-0.42	30.13	20.08
Levered Free Cash Flow, 5 Yr. CAGR %	78.53	59.47	-33.35	-5.29	4.18
Unlevered Free Cash Flow, 5 Yr. CAGR %	78.61	61.67	-35.48	-5.84	3.74